GCG and Alzheimer disease: In the present study, an engineered strain MG1363-pMG36e-GLP-1 was generated to continuously express GLP-1, and the LPS-induced AD model and MPTP-induced PD model were developed to evaluate the treatment effect of MG1363-pMG36e-GLP-1 on AD and PD.